Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Non-Current Debt (2023 - 2025)

Cannabis Bioscience International Holdings' Non-Current Debt history spans 3 years, with the latest figure at $249500.0 for Q4 2025.

  • For Q4 2025, Non-Current Debt changed 0.0% year-over-year to $249500.0; the TTM value through Nov 2025 reached $249500.0, changed 0.0%, while the annual FY2025 figure was $249500.0, 0.06% changed from the prior year.
  • Non-Current Debt for Q4 2025 was $249500.0 at Cannabis Bioscience International Holdings, roughly flat from $249500.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $249501.0 in Q1 2025 and bottomed at $249361.0 in Q2 2024.
  • The 3-year median for Non-Current Debt is $249500.0 (2023), against an average of $249486.2.
  • The largest annual shift saw Non-Current Debt decreased 0.06% in 2024 before it rose 0.06% in 2025.
  • A 3-year view of Non-Current Debt shows it stood at $249500.0 in 2023, then changed by 0.0% to $249500.0 in 2024, then changed by 0.0% to $249500.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Non-Current Debt are $249500.0 (Q4 2025), $249500.0 (Q3 2025), and $249500.0 (Q2 2025).